Till Koch at Division of Infectious Diseases University Medical Center Hamburg‐Eppendorf Hamburg Germany - Research Interests, Publications & Academic Profile

Till Koch

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

70%

Virology

100%

Sars-cov-2

40%

Vaccinology

40%

Immunotherapy

40%

Antibodies

30%

Mucosal Immunology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach

Article Link

Year:

2024

Focussed Assessment with Sonography in acute Lassa Fever (FASLa): Development of a point-of-care protocol and description of common ultrasound findings.

Article Link

Year:

2023

Early neuroborreliosis with leg paresis mimicking herpes zoster

Article Link

Year:

2023

Endocarditis guidelines: call for an interdisciplinary approach

Article Link

Year:

2023

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022

Article Link

Year:

2023

Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability

Article Link

Year:

2023

Pharmacokinetics of ribavirin in the treatment of Lassa fever: An observational clinical study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria

Article Link

Year:

2022

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

Article Link

Year:

2022

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Article Link

Year:

2022

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series

Article Link

Year:

2021

[Mild COVID-19 disease in healthcare workers at a German university clinic : The "first wave" at the University Medical Center Hamburg-Eppendorf].

Article Link

Year:

2021

Less than you’d think—a prospective study on MRSA-colonization in healthy travellers

Article Link

Year:

2021

Correlates of Vaccine-Induced Protection against SARS-CoV-2

Article Link

Year:

2021

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria.

Article Link

Year:

2020

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins

Article Link

Year:

2020

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.

Article Link

Year:

2020

Collaborators9

Leonie Marie Weskamm

University Medical Center Hamburg-Eppendorf

GERMANY

Bart L. Haagmans

Principal Investigator / Associate Professor - PhD

Erasmus MC

NETHERLANDS

Mirjam Groger

Bernhard Nocht Institute for Tropical Medicine

GERMANY

Johann von Felden

University Medical Center Hamburg-Eppendorf

GERMANY

Marcel Mueller

Group leader/ Prof. Dr. rer. nat.

Charité - Universitätsmedizin Berlin

GERMANY

Stephan Günther

Head

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

Michael Ramharter

Professor

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

Bruna Mara Silva Seco

University of Idaho

UNITED STATES

Dorothee Schwinge

University Medical Center Hamburg-Eppendorf

GERMANY

How do Indian students reach out?

Meet Kite AI